CareRx Corporation
CHHHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.31 | 0.18 | -0.32 | 0.30 |
| FCF Yield | 24.68% | 21.97% | 7.31% | 0.08% |
| EV / EBITDA | 8.14 | 7.13 | -370.64 | 13.94 |
| Quality | ||||
| ROIC | 2.68% | 1.44% | 3.59% | 1.95% |
| Gross Margin | 29.47% | 28.24% | 28.80% | 28.66% |
| Cash Conversion Ratio | -8.44 | -5.06 | -0.65 | -0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.33% | 12.18% | 33.02% | 28.21% |
| Free Cash Flow Growth | 59.94% | 114.22% | 5,599.35% | 108.86% |
| Safety | ||||
| Net Debt / EBITDA | 3.08 | 3.68 | -175.17 | 4.47 |
| Interest Coverage | 0.49 | 0.33 | 0.52 | 0.33 |
| Efficiency | ||||
| Inventory Turnover | 14.64 | 13.54 | 13.39 | 10.41 |
| Cash Conversion Cycle | 13.01 | 22.56 | 21.14 | 23.32 |